Oliver Lagore Vanvalin Investment Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.4K | Buy |
+51
| New | +$25.4K | 0.01% | 319 |
|
|
2024
Q4 | $26.5K | Hold |
51
| – | – | 0.01% | 323 |
|
|
2024
Q3 | $31.5K | Hold |
51
| – | – | 0.01% | 294 |
|
|
2024
Q2 | $28.2K | Sell |
51
-6
| -11% | -$3.32K | 0.01% | 301 |
|
|
2024
Q1 | $33.1K | Sell |
57
-4
| -7% | -$2.33K | 0.01% | 279 |
|
|
2023
Q4 | $32.4K | Hold |
61
| – | – | 0.01% | 256 |
|
|
2023
Q3 | $30.9K | Buy |
61
+1
| +2% | +$506 | 0.01% | 288 |
|
|
2023
Q2 | $31.3K | Sell |
60
-11
| -15% | -$5.74K | 0.01% | 307 |
|
|
2023
Q1 | $40.9K | Hold |
71
| – | – | 0.02% | 206 |
|
|
2022
Q4 | $39.1K | Sell |
71
-1
| -1% | -$551 | 0.02% | 201 |
|
|
2022
Q3 | $37K | Buy |
72
+8
| +13% | +$4.11K | 0.02% | 192 |
|
|
2022
Q2 | $35K | Hold |
64
| – | – | 0.02% | 212 |
|
|
2022
Q1 | $38K | Buy |
+64
| New | +$38K | 0.03% | 198 |
|